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ARTICLE
Lipoteichoic acid deficiency permits normal growth
but impairs virulence of Streptococcus pneumoniae
Nathalie Heß1, Franziska Waldow 2, Thomas P. Kohler 1, Manfred Rohde3, Bernd Kreikemeyer 4,
Alejandro Gómez-Mejia 1, Torsten Hain5, Dominik Schwudke2, Waldemar Vollmer6,
Sven Hammerschmidt 1 & Nicolas Gisch 2
Teichoic acid (TA), a crucial cell wall constituent of the pathobiont Streptococcus pneumoniae,
is bound to peptidoglycan (wall teichoic acid, WTA) or to membrane glycolipids (lipoteichoic
acid, LTA). Both TA polymers share a common precursor synthesis pathway, but differ in the
final transfer of the TA chain to either peptidoglycan or a glycolipid. Here, we show that
LTA exhibits a different linkage conformation compared to WTA, and identify TacL
(previously known as RafX) as a putative lipoteichoic acid ligase required for LTA assembly.
Pneumococcal mutants deficient in TacL lack LTA and show attenuated virulence in
mouse models of acute pneumonia and systemic infections, although they grow normally
in culture. Hence, LTA is important for S. pneumoniae to establish systemic infections, and
TacL represents a potential target for antimicrobial drug development.
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Streptococcus pneumoniae (the pneumococcus) is a humanpathobiont that not only colonizes asymptomatically therespiratory tract, but is also capable of causing diseases
such as otitis media, acute sinusitis, pneumonia, meningitis, and
sepsis1,2. The cell surface of this Gram-positive bacterium consists
of a peptidoglycan-wall teichoic acid (PGN-WTA) cell wall and is
shielded by a capsular polysaccharide (CPS), allowing the cell to
evade recognition by the innate immune system of the host3. Like
most Gram-positive bacteria S. pneumoniae also possesses a
lipoteichoic acid (LTA), which is anchored to the cell membrane
by a glycolipid moiety. Both types of teichoic acid (TA) bind
choline-binding proteins (CBPs), an important class of cell
surface proteins involved in peptidoglycan remodeling
and interactions with host factors. In contrast to many other
Gram-positive bacteria, pneumococci contain a structurally
unique, complex LTA4. Similar LTA structures are known
only for other members of the mitis group of streptococci,
Streptococcus mitis5 and Streptococcus oralis6. Pneumococcal LTA
(pnLTA) is composed of a lipid anchor (α-D-Glcp-(1→ 3)-dia-
cylglycerol) and 4 to 8 repeating units (RUs), each one consisting
of a pseudo-pentasaccharide ((→4)-6-O-P-Cho-α-D-GalpNAc-
(1→ 3)-6-O-P-Cho-β-D-GalpNAc-(1→ 1)-Rib-ol-5-P-(O→ 6)-
β-D-Glcp-(1→ 3)-AATGalp-(1→ )). The terminal RU is found
both with and without a 6-O-phosphorylcholine (6-O-P-Cho)
substitution. The first RU is β-1-linked via the AATGalp to the
lipid anchor, whereas all other RUs are α-1-linked7. Pneumo-
coccal strains containing only one P-Cho per RU lack the P-Cho
at β-D-GalpNAc8. Some of the hydroxyl groups of Rib-ol-5-P are
substituted with D-Ala7,9. The RUs of pneumococcal WTA
(pnWTA) have the same chemical structure as the RUs of the
LTA, but it is not clear whether there is a specific linkage unit
between WTA chains and PGN as in other bacteria10,11. Based
on chemical hydrolysis experiments, it was proposed that
pnWTA is linked to the PGN by a phosphodiester to the
hydroxyl group at C-6 of the MurNAc10, which is thought to
be the general mechanism for WTA attachment (reviewed in
ref. 12). However, cell wall fragments containing an intact linkage
between pnWTA and PGN were not isolated or analyzed in
previous studies and therefore the nature of this linkage has
remained elusive10,13,14.
A recent bioinformatic analysis indicates that the pneumo-
coccal TA (pnTA) precursor chains are synthesized by a shared
biosynthetic pathway15. A key step involves the transport of an
undecaprenyl-diphosphate(Und-PP)-linked TA precursor across
the cytoplasmic membrane by TacF (for “teichoic acid flippase”),
which belongs to a family of polysaccharide transmembrane
transporters16. Members of the LytR-Cps2A-Psr (LCP) protein
family have been proposed to attach anionic polymers to PGN in
Gram-positive bacteria17. The absence of all LCP orthologues
from Staphylococcus aureus (LytR, CpsA, and Psr) leads to the
secretion of WTAs to the extracellular medium, thereby reducing
significantly the phosphate content of the cell envelope18.
All three pneumococcal LCP orthologues appear to have semi-
redundant roles in retaining the pneumococcal CPS at the cell
surface. It was suggested that the three LCP proteins attach CPS
and TA polymers to PGN, and that the LCP enzymes are required
to form the LTA19. However, another protein, RafX (SPD_1672
in strain D39, SP_1893 in strain TIGR4), has been proposed to
assemble pnWTA based on the reduced amount of WTA detected
by an antibody in RafX-deficient strains, which also showed
impaired colonization capabilities, growth defects, and attenua-
tion in virulence20,21.
Here we report the elucidation of the linkage between pnWTA
and PGN, which is different in its configuration compared to
the linkage between TA chains and the glycolipid anchor in
pnLTA. We have also analyzed pnTAs from a nonencapsulated
strain and the isogenic rafX mutant by high-resolution mass
spectrometry (MS) and nuclear magnetic resonance (NMR)
spectroscopy. We show that RafX (SPD_1672, SP_1893) is
required for the synthesis of pnLTA, but not pnWTA. We
propose that this protein is most likely involved in ligation of
pnTA precursor chains onto the glycolipid anchor, and rename
RafX as TacL (for “lipoteichoic acid ligase”). Furthermore, we
show that tacL mutants grow with normal rate and morphology
in culture but are attenuated in two mouse models of infection.
Results
Linkage structure of pnWTA to PGN. In order to determine the
linkage structure of pnWTA, we isolated the PGN-WTA complex
of S. pneumoniae D39ΔcpsΔlgt using a previously published
procedure11. This strain lacks the CPS and the gene encoding for
the lipoprotein diacylglyceryl transferase (Lgt) and is therefore
deficient in lipidation of prelipoproteins7,22. Isolated pnLTA from
this strain was shown to be structurally identical with that of its
parental strain D39Δcps and to be free of Toll-like receptor
2 stimulating activity7. Therefore, we considered this strain to be
best suitable for the investigation of the PGN-WTA complex
and for prospective cell stimulation assays, avoiding possible
contamination with lipoproteins. The cell wall was digested with
pneumococcal amidase LytA and the resultant peptide-free PGN
glycan chains carrying pnWTA were isolated by gel permeation
chromatography (GPC) (Supplementary Fig. 1a). This material
was digested with lysozyme and mutanolysin, producing pnWTA
chains bound to a variety of small PGN fragments. The mixture
was further purified by another GPC step (Supplementary
Fig. 1b). Figure 1a shows the relevant section of the mass spec-
trum obtained from this material. The identified molecules
correspond to pnWTA chains with five to seven RUs bound by a
phosphate moiety to di-, tri -, or tetramers of MurNAc-GlcNAc
disaccharides.
Analysis by 31P NMR revealed the occurrence of additional
signals when compared to de-O-acylated pnLTA isolated from
the same strain7 in the chemical shift range between δP −1.0 and
−1.3 (Fig. 1b). Using a 1H, 31P-correlated heteronuclear multiple
quantum correlation (HMQC) NMR experiment (Fig. 1c), this
bridging phosphate was determined to be an α-1-phosphate
because of the cross correlation into the broadened signals
(caused by the heterogeneity of the PGN sugar fragments) in the
1H NMR spectrum between δH 5.51 and 5.47 ppm. Based on
further NMR analysis, we assigned this α-1-phosphate to
AATGalp, which verifies the direct linkage of pnWTA to PGN.
The respective 1H, 13C HSQC NMR spectrum is shown in
Supplementary Fig. 2; the complete NMR chemical shift data for
the pnWTA are listed in Supplementary Table 1. The structural
elucidation of this linkage clarified the last remaining question
about the chemical structure of pnTAs: in the final model
(Fig. 1d), both TA types contain the same pseudo-
pentasaccharide building blocks, whereas the terminal RU can
occur with or without 6-O-P-Cho-substitution on both GalpNAc
moieties. In pnLTA, the first repeating unit is β-1-linked to the
lipid anchor (α-D-Glcp-(1→ 3)-DAG). By contrast, the pnWTA
is linked directly—without the presence of an additional linkage
unit—to the PGN by an AATGalp-α-1-phosphate. These different
anomeric linkages (β-1 and α-1, respectively) for pnLTA and
pnWTA implies that different ligases probably catalyze the
linkage reactions for the two pnTAs.
TacL mutants lack pnLTA and attach pnWTA to PGN. Based
on the different linkage structures of pnWTA and pnLTA, we
hypothesized that the ligase for pnLTA assembly on the glycolipid
is not an LCP phosphotransferase enzyme. A candidate gene
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Fig. 1 Structural analysis of pnWTA bound to small PGN saccharides from S. pneumoniae D39ΔcpsΔlgt and chemical structures of pnTAs. a Section of the
charge deconvoluted ESI-FT-ICR-MS spectrum (acquired in negative-ion mode). Signals for molecules 1–11 represent pnWTA with 5–7 RUs bound to small
PGN-derived saccharides; observed and calculated masses are given. *only second isotopic peak was observable. b Section (δP 5.0-(−5.0)) of the 31P
NMR including assignment of signals. Magnification shows 31P NMR signals that are not observable in pnLTA preparations7 (compare Fig. 2). c Section
(δH 6.00-3.40; δP 3-(−2)) of the respective 1H, 31P HMQC NMR spectrum. The important region for the linkage phosphate is magnified. Cross
correlation of the phosphates between δP −1.0 and −1.3 into the broadened signal in 1H NMR (δH 5.51–5.47) could be assigned to the anomeric proton of
α-AATGalp, proving the stereochemistry of this bridging phosphate is an α-1-linked atom. d Chemical structures of pnTAs. RUs of both TAs contain
the same pseudo-pentasaccharide building blocks, whereby the terminal RU can occur with or without 6-O-P-Cho-substitution on both GalpNAc. A few
mono-P-Cho-substituted TAs lack the P-Cho at β-GalpNAc (R′). In pnLTA, the first RU is β-1-linked to the lipid anchor (α-D-Glcp-(1→ 3)-DAG); consistent
with the α-configuration of the respective linkage of pnWTA to PGN. All other RUs are α-glycosidically linked to the previous one. Hydroxyl groups of ribitol
can be substituted by D-alanine (D-Ala; R). n number of RU; R′′ and R′′′, alkyl or alkenyl residues of fatty acid chains in lipid anchor (summarized in ref. 8)
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encoding the LTA ligase was recently identified as rafX20, here-
after called tacL. Hence, we isolated pnLTA from the isogenic
tacL mutants D39ΔcpsΔtacL and TIGR4ΔcpsΔtacL, their
parental strains and the complemented mutants (Supplementary
Table 2) as described7. The tacL deletion and its complementa-
tion were verified in the respective encapsulated and non-
encapsulated S. pneumoniae D39 strains by real-time quantitative
PCR (qRT-PCR; Supplementary Fig. 3).
The chromatogram in Supplementary Fig. 4 is a representative
hydrophobic interaction chromatography (HIC) purification
of pnLTA from strain D39Δcps; the normalized phosphate
content is depicted in the upper panel. The 31P NMR spectra
of the corresponding hydrazine-treated pnLTAs are shown in
Fig. 2. The tacL mutants lacked detectable amounts of pnLTA
(Fig. 2b, e), while pnLTA was present in both the complemented
(Fig. 2c, f) and the isogenic parental strains (Fig. 2a, d) indicating
that TacL is required for LTA synthesis. The MS analysis of
hydrazine-treated pnLTA from in trans-complemented and
parental strains resulted in nearly identical profiles indicating
that the expressed tacL gene was functional (Supplementary
Fig. 5). Moreover, the 31P NMR spectra of the PGN-WTA
complex after LytA digestion (Supplementary Fig. 6) prove that
pnWTA was present in all investigated strains, including the tacL
mutants, thus showing that TacL is not needed for the synthesis
of the WTA-PGN linkage.
The genomes of the nonencapsulated tacL mutants and their
isogenic parental strains were sequenced and compared to
exclude the possibility of compensatory mutations. For strain
D39ΔcpsΔtacL, we identified four single-nucleotide polymorph-
isms (SNPs) in comparison to its parental strain D39Δcps
(Supplementary Table 3). Two are located in intergenic regions,
the two others are placed in spd_0768 (Asp297Gly) and spd_1179
(Ala141Thr), respectively. The latter encodes a predicted
lanthionine synthetase, whereas Spd_0768 (CozE) has recently
been described as a member of the MreCD complex of
S. pneumoniae that directs the activity of PBP1a to the mid-cell
plane, where it promotes zonal cell elongation and normal
morphology23. The identified variants in the genome of strain
TIGR4ΔcpsΔtacL are listed in Supplementary Table 4. Beside
three variations in intergenic regions, our analysis identified three
SNPs in sp_1894 and two SNPs in the pseudogene sp_rs12410
directly located in between tacL and sp_1894, with a small overlap
with the end of the ORF of sp_1894. However, PCR amplification
and DNA sequencing of these specific regions disproved two of
these SNPs. The confirmed SNPs in sp_1894, encoding GtfA
(a transferase involved in glycosylation of pneumococcal serine-
rich repeat adhesins with O-linked N-acetyl-D-glucosamine24),
are Ile370Val and a silent one (Glu432Glu). Furthermore, a 1 bp
deletion causing a frameshift in sp_1914, encoding a putative
membrane protein of unknown function, was identified. None of
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Fig. 2 31P NMR spectra of pnLTA preparations. Sections (δP 3-(−3)) of 31P NMR spectra measured from LTA isolated from pneumococcal strains
a D39Δcps, b D39ΔcpsΔtacL, c D39ΔcpsΔtacL pBAV-tacL, d TIGR4Δcps, e TIGR4ΔcpsΔtacL, and f TIGR4ΔcpsΔtacL pBAV-tacL. a, c, d, f Hydrazine-treated
LTA was used, for tacL knockout mutants (b, e) the typical LTA-containing fractions from the HIC purifications (compare Supplementary Fig. 4) were
measured without prior hydrazine treatment
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these mutations are likely to cause any alteration in the pnTA
structure.
In summary, whole-genome sequencing and subsequent
analysis of genomic variations in the tacL mutants apparently
excluded secondary mutations with expectable impact on pnTA
biosynthesis, especially because none of the observed variations
and therefore potentially compensatory mutations took place in
both serotypes. Taken together, our data support the hypothesis
that TacL is involved in pnLTA assembly, and not in pnWTA
assembly as was previously proposed20.
Loss of TacL does not perturb pneumococcal physiology. The
loss of LTA is lethal to S. aureus under standard laboratory
conditions25. Hence, we tested the impact of tacL deletion on
pneumococcal growth in two complex media and a chemically
defined medium (RPMImodi)26 (Supplementary Fig. 7a). TacL
deficiency slightly affected growth of the encapsulated D39 tacL
mutant in RPMImodi. However, this effect could not be observed
for the nonencapsulated strain or for the growth of the encap-
sulated and nonencapsulated strains in the two complex media.
The complemented, nonencapsulated mutant revealed reduced
growth in RPMImodi compared to both the wild-type and the
TacL-deficient strain. This is possibly an effect of the plasmid-
based in trans complementation of the mutant due to a gene
dosage effect of tacL by multiple plasmid copies. The tacL mutant
was slightly affected in detergent-induced autolysis, increasing
the rate of cell lysis in the presence of 0.01% Triton X-100 in
the encapsulated strains in comparison to the wild-type strain. In
the nonencapsulated strains, the effect was less pronounced
(Supplementary Fig. 7b).
We next analyzed by field emission scanning and transmission
electron microscopy (FESEM, TEM) how LTA deficiency affects
pneumococcal cell morphology and cell division in strain
D39Δcps grown in complex medium (Fig. 3a) or in RPMImodi
(Supplementary Fig. 8). No significant differences in cell size or
the localization of division septa between the parental strain, the
tacL mutant, and complemented mutant were observed for both
growth conditions. Furthermore, the amount of capsule was
similar in strains with or without tacL, as determined by a flow
cytometric assay with an antiserum directed against the capsule
type 2 (Fig. 3b).
It has been proposed that WTA represent ~90% of the total TA
content in S. pneumoniae27; a similar WTA/LTA ratio was
determined for its close relative S. oralis28. If LTA constitutes
about 10% of pneumococcal TAs, the complete lack of LTA in the
tacL mutant may not lead to a significant decrease in
the measurable P-Cho content of the pneumococcal cell wall.
We quantified the amount of P-Cho in the cell wall of the
different strains with the P-Cho-specific antibody TEPC-15
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Fig. 3 Analysis of pneumococcal cell morphology and cell division by electron microscopy and quantification of the capsule content. a FESEM and TEM
ultrathin sections revealed no visible differences in the cell morphology and cell division septa morphology between nonencapsulated D39 wild-type (WT),
tacL mutant (ΔtacL), or complemented mutant (ΔtacL pBAV-tacL) grown in THY medium. Scale bars= 2 µm (FESEM, left panel), 0.2 µm (FESEM, right
panel), 0.2 µm (TEM). b Flow cytometric analysis of the capsule content. Bacteria were grown in THY medium to A600= 0.35–0.45, washed and incubated
with serum against type 2 capsule followed by a secondary Alexa488-labeled antibody. The values are represented as the geometrical mean fluorescence
intensity multiplied with percent-gated events. Results are expressed as means± s.d. (each experiment was performed at least three times). ***p< 0.001;
*p< 0.05; ns not significant (Student's unpaired t test)
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(Fig. 4a and Supplementary Fig. 9a). All strains contained a
similar amount of P-Cho. Unfortunately, pnTA-specific anti-
bodies are not currently available. For further quantification of
the TAs, we made use of an anti-Forssman antibody that
recognizes the terminal sugar residues (α-D-GalpNAc-(1→ 3)-β-
D-GalpNAc-(1→ )) of pnWTA and pnLTA7. Comparable
amounts of the Forssman antigen were detected by flow
cytometry in the tacL mutant, wild-type and complemented
mutant. In summary, the loss of LTA in the tacL mutant appears
to be compensated either by a higher abundance of WTA on the
cell surface or by the accumulation of TA precursor chains.
Another possibility could be that the loss of pnLTA is simply not
measureable due to its low abundance in comparison to the
pnWTA. At any rate, we can exclude a dramatic decrease of the
cell wall P-Cho content in tacL mutants.
The amount of cell surface-attached CBPs depends on the
amount of P-Cho-loaded TAs, which serve as an anchor for these
proteins. We determined the presence and amount of various
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Fig. 4 Quantitative analysis of teichoic acids and choline-binding proteins. Bacteria were grown in THY medium to A600=0.35–0.45 (for LytA 0.4 and 0.8),
washed and incubated with antibodies. a The amount of P-Cho and the Forssman antigen of teichoic acids were determined using specific primary antibodies
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CBPs on the cell surface of the nonencapsulated strains using
specific polyclonal antibodies against different CBPs (Fig. 4b and
Supplementary Figs. 9b and 10). The pneumococcal surface
proteins PspC and Pce were slightly, but not significantly,
enhanced in the tacLmutant, whereas CbpJ (a protein involved in
host–pathogen interaction)29 was slightly reduced. Several other
CBPs such as PspA, the major autolysin LytA (at A600 0.4 and 0.8)
and the CBPs CbpL and CbpG were unaltered in the tacL mutant,
consistent with the similar content of P-Cho and TA chain ends
as determined with the antibodies. Taken together, these results
suggest that the tacL mutant carries largely unaltered amounts of
P-Cho in its cell wall despite the absence of LTA.
Influence of pnLTA on pneumococcal adhesion and phagocy-
tosis. To elucidate the role of pnLTA in bacterial adhesion to
human lung epithelial cells, A549 cells were infected with the
nonencapsulated D39 strain, its isogenic tacL mutant, or its
complemented mutant. Immunofluorescence microscopy
revealed that the TacL-deficient strain showed a significant
decrease in the ability to adhere to A549 cells after 2 or 4 h of
infection, whereas the adherence of the complemented mutant
was comparable to that of the parental strain (Supplementary
Fig. 11).
The impact of LTA on pneumococcal phagocytosis by PMA-
differentiated (phorbol 12-myristate 13-acetate) THP-1 cells was
evaluated in antibiotic protection assays and by double immuno-
fluorescence staining. A time-dependent uptake of pneumococci
could be monitored for all tested strains with a moderate increase
for the complemented mutant in the antibiotic protection assay
compared to the parental strain D39Δcps (Supplementary
Figs. 12a and 13). The intracellular killing of the TacL-deficient
mutant within the phagocytes was moderately but significantly
decreased after 1 or 2 additional hours of incubation as
determined by antibiotic protection assays (Supplementary
Fig. 12b). In conclusion, pneumococcal adherence to epithelial
cells is significantly affected by the loss of LTA, whereas bacterial
uptake by phagocytes was not affected.
Loss of TacL attenuates pneumococcal virulence. We used two
different mouse models of infection to assess the impact of the
TacL deficiency on pneumococcal pathogenesis (Fig. 5a, b and
Supplementary Fig. 14). In the acute pneumonia model (Fig. 5a,
Supplementary Fig. 14), mice were infected intranasally with
S. pneumoniae D39lux, D39luxΔtacL, or the complemented
mutant. In case of the wild type, 90% of the infected mice
developed pneumonia, which resulted in severe sepsis and death
of the mice. By contrast, only 30% of the mice infected with the
tacL mutant showed severe signs of pneumonia and sepsis. The
course of disease is clearly prolonged in mice infected with the
TacL-deficient strain. Importantly, complementing the tacL
mutant in trans restored the phenotype of the wild type. In the
systemic infection (sepsis) model (Fig. 5b), mice were infected
intraperitoneally with the encapsulated D39lux strain, D39lux-
ΔtacL, or the complemented mutant and the severity of disease
was monitored over time. Mice infected with the wild-type strain
or the complemented mutant showed earlier onset of disease and
died significantly sooner than mice infected with the tacL mutant.
In summary, loss of TacL resulted in a significantly attenuated
virulence, indicating an essential role of LTA in the pathophy-
siology of pneumococci.
Discussion
We show in this work that TacL (also known as RafX, SPD_1672
(strain D39) or SP_1893 (in TIGR4)) is required for pnLTA
formation in S. pneumoniae. We propose that TacL is a lipo-
teichoic acid ligase acting in the final step of pnLTA synthesis
(Fig. 6). Our data are not consistent with the previously hypo-
thesized role of SPD_1672 and its homologs in the biosynthesis of
pnWTA, which was based on antibody detection methods and
did not involve a detailed structural analysis of WTA or LTA.
Remarkably, with the exception of few choline-utilization
enzymes30, most of the enzymes in the predicted pathway of
pnTA synthesis15 remain uncharacterized.
The undecaprenyl-diphosphate (Und-PP)-linked monomeric
repeats are polymerized by the RU polymerase, transported
through the cytosolic membrane by TacF and are finally trans-
ferred onto the PGN or the glycolipid anchor. We show here that
the linkage conformation in pnWTA differs from that of pnLTA;
the AATGalp moiety within the first RU of pnLTA is β-con-
figurated7, while the respective AATGalp in pnWTA has the
α-configuration. This observation suggests that the final reactions
in pnLTA and pnWTA assembly differ mechanistically and that
the reactions are likely catalyzed by enzymes from different
classes. The transfer of the TA precursor chains onto the PGN is
most likely performed by the LCP proteins Psr, LytR, and
Cps2A19, which belong to the same family of phospho-
transferases. Here the TA chain is transferred with one phos-
phate, thus retaining the anomeric configuration of the AATGalp
moiety of the first RU. By contrast, in LTA synthesis, a new
glycosidic bond is formed between the glucose moiety of
the glycolipid anchor and the first AATGalp. This reaction
inverts the stereochemistry of the anomeric carbon, leading to the
β-configuration of the AATGalp moiety of the first RU in pnLTA.
A similar mechanism has been described in the biosynthesis of
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Fig. 5 Impact of TacL deficiency on pneumococcal virulence. Survival of CD-1 mice after a intranasal infection with ~2.5 × 107 bioluminescent S. pneumoniae
D39lux wild type, D39luxΔtacL, or the complemented mutant (D39ΔtacL pBAV-tacL) in the pneumonia model (n= 10) (see also Supplementary Fig. 14
for bioluminescence images). b Survival of CD-1 mice (n= 12) after intraperitoneal infection with ~3 × 103 pneumococci in the systemic infection model.
**p< 0.01; ns not significant (Log-rank (Mantel–Cox) test)
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01720-z ARTICLE
NATURE COMMUNICATIONS |8:  2093 |DOI: 10.1038/s41467-017-01720-z |www.nature.com/naturecommunications 7
PCh
oGlc GalNAc
Phosphate
Choline
Ribitol
Glycerol Fatty acids
P
Rib
Cho
Cho
P
Rib
P Cho
Cho
n
P
Rib
Cho
Cho
P
P
P
P
P
P
Rib
P Cho
Cho
n
P
Rib
Cho
Cho
P
P
P
P
P
P
Rib
P Cho
Cho
n
P
Rib
Cho
Cho
P
P
P
P
P
P
Rib
P Cho
ChoP
P
P
Peptidoglycan
P
Rib
Cho
Cho
P
Rib
P Cho
Cho
n
P
Rib
Cho
Cho
P
P
P
P
P
P
P Undecaprenyl
diphosphateP
α
α
α
α
α
β
P
Rib
Cho
Cho
P
P
α
α
α
P
Rib
Cho
Cho
P
P
α
α
α
R
ib
TacF
LCP TacL
RU
Poly-
merase
CM
WTA
LTA
AATGal
Fig. 6 Last steps in the TA biosynthesis pathway in S. pneumoniae. The Und-PP-linked monomeric repeats are polymerized by the RU polymerase and
transported through the cytosolic membrane by TacF. The complete biosynthesis pathway is reviewed and discussed in ref. 15. Finally, the pnTA precursor
chain is transferred onto the PGN to form the pnWTA or onto the glycolipid anchor to form the pnLTA, respectively. The transfer to the PGN is performed
—most likely in a semi-redundant manner19—by the LCP proteins Psr, LytR, and Cps2A. Here the TA chain is transferred including one phosphate, thus
retaining the anomeric α-configuration of the AATGalp moiety of the first RU. In pnLTA formation, a new glycosidic bond between the glucose moiety of
the glycolipid anchor and the first AATGalp is formed. We propose that TacL may catalyze this reaction, which inverts the stereochemistry of the anomeric
carbon leading to the β-configuration of the AATGalp moiety of the first RU in pnLTA. From these observations, it can be concluded that the Und-PP-linked
pnTA precursor chains are synthesized with all AATGalp moieties in the α-configuration. AATGal 2-acetamido-4-amino-2,4,6-trideoxygalactose, CM
cytoplasmic membrane, GalNAc N-acetylgalactosamine, Glc glucose, LCP LytR-Cps2A-Psr family protein
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01720-z
8 NATURE COMMUNICATIONS |8:  2093 |DOI: 10.1038/s41467-017-01720-z |www.nature.com/naturecommunications
the lipopolysaccharide (LPS) of Gram-negative bacteria when
the O-antigen chain is attached to the core oligosaccharide. The
O-antigen is synthesized as an Und-PP-linked precursor and is
translocated across the cytosolic membrane by different path-
ways31. In several published LPS structures, the first sugar of
the O-antigen always has the β-configuration, whereas it has the
α-configuration in the Und-PP-linked precursor32. This reaction
is catalyzed by the O-antigen ligase WaaL (RfaL).
TacL of S. pneumoniae may be located in the cytoplasmic mem-
brane with nine transmembrane helices (as predicted by TMbase25;
http://embnet.vital-it.ch/software/TMPRED_form.html)33 and a
Wzy_C Pfam domain (STRING database v. 10.0). Wzy_C super-
family domains are characteristic of enzymes involved in the
synthesis of O-antigens in Gram-negative bacteria, including O-
antigen ligases. Pneumococcal TacL is composed of 397 amino acids,
comparable to the length of the RfaL O-antigen ligase of E. coli K12
(419 aa) or WaaL of Pseudomonas aeruginosa PAO1 (401 aa), which
are predicted by TMbase to have similar secondary structures to
TacL. TacL shares significant sequence similarities to a stretch of 208
amino acids in RfaL (21.6% identity, 57.7% similarity) and to a 378
amino acid stretch in WaaL (18.8% identity, 49.2% similarity). The
attachment of carbohydrate polymers to glycolipids to form complex
cell wall glycopolymers in Gram-positive and Gram-negative bacteria
thus appears to share a conserved mechanism.
The repeating units of the wall and lipoteichoic acids of
pneumococci comprise identical RUs, which is a special feature
that differs from most other Gram-positive bacteria. Most of the
Firmicutes, like S. aureus, possess WTAs built up of ribitol-
phosphate RUs, whereas the LTA comprises repeating
glycerol–phosphate units34,35. The total loss of WTAs in S. aureus
leads to reduced adherence to host cells, while LTA is essential for
growth and cell division25,36,37. Here we show that a S. pneu-
moniae tacL mutant is unable to anchor the LTA to the mem-
brane glycolipid. Strikingly, all strains showed a comparable
growth in complex media, and even in chemically defined med-
ium (RPMImodi) only minor differences could be observed. Only
the encapsulated TacL-deficient D39 mutant was slightly affected
in growth in RPMImodi. This observation is in accordance with
previous findings from Wu et al.20, showing also a slightly
delayed growth of a RafX (Spd_1672)-deficient D39 strain in
semisynthetic casein hydrolysate medium supplemented with
yeast extract. Inconsistent with our study, Wu et al.20 described
altered cell shape and division for their mutant strain. However,
the published rafX mutant was not analyzed by whole-genome
sequencing, and the authors did not discuss possible secondary
mutations affecting morphology20. Additionally, the com-
plemented, nonencapsulated strain (D39ΔcpsΔtacL pBAV-tacL)
was affected during growth in RPMImodi. However, this could be
due to the presence of multiple tacL gene copies within the
complemented mutant. As mentioned, tacL mutants generated by
us did not exhibit changes in cell morphology or division com-
pared to parental strains, which is different to LTA-deficient
S. aureus mutants37. Hence, contrary to findings in other
Gram-positive species, we show here that LTA is not essential in
S. pneumoniae, which might be due to the structural identity of
pnLTA and pnWTA. LTA forms ~10% of total teichoic acid in
the pneumococcal cell wall27. The total amount of pnTA in the
tacL mutant was unaffected according to the quantification of
P-Cho and chain ends using specific antibodies, which suggests
that an increase in pnWTA content or the presence of carrier
lipid-bound pnTA chains may compensate for the loss of pnLTA.
Alternatively, the amount of pnLTA may be too low to be sub-
stantiated reliably using currently available methodologies.
Pneumococcal TAs carry P-Cho modifications, which are
essential for bacterial growth38. CBPs represent a group of
pneumococcal surface proteins that are non-covalently bound to
the P-Cho moieties of pnLTA and pnWTA39. Several CBPs have
important functions in bacterial physiology and virulence40–42.
Consistent with the quantification of pnTA content, we found
that five out of seven tested CBPs were unchanged in abundance
in the tacL mutant. The amounts of CbpJ, a protein interacting
with the C-reactive protein of humans29, and the phosphor-
ylcholine esterase Pce were only slightly altered in the tacL
mutant. Thus, changes in abundance of CBPs can be excluded
from the cause of the attenuation of the tacL mutant in pneu-
monia and sepsis infection models. However, the loss of pnLTA
may influence the membrane integrity and/or fluidity, which
affects survival of mutants deficient in TacL in vivo but cannot be
visualized by electron microscopy. In a previous study7, we have
shown that LTA preparations of a pneumococcal Δlgtmutant had
residual immunostimulatory properties when tested in human
mononuclear cells (hMNCs), in the absence of TLR2-stimulating
activity. This was consistent with an observed stimulation of
hMNCs by a synthetic short-chain analog of pnLTA43. The
receptor(s) and mechanisms of general LTA sensing by the innate
immune system have not been investigated in depth. However,
some studies suggest the involvement of different pathways of the
complement system in the interaction with S. pneumoniae and
pnTAs (summarized in ref. 8).
Potentially, the lack of such interactions with TacL deficient
and therefore LTA lacking pneumococcal mutants could con-
tribute to the observed impaired virulence in the mouse sepsis
model. The significant decrease in adhesion to human epithelial
cells observed in cell culture infections with A549 cells could
explain the observed pathophenotype in the pneumonia model.
Due to its fundamental and essential function under in vivo
conditions, TacL represents a potential target for antimicrobial
substances.
Methods
Bacterial strains and growth conditions. Bacterial strains are listed in Supple-
mentary Table 2. Escherichia coli were cultured on Luria Broth (LB) plates or in
liquid LB medium, supplemented with 200 µg ml−1 erythromycin at 37 °C.
Transformation of E. coli with plasmid DNA was carried out using chemically
competent cells. S. pneumoniae serotype 2 D39 and serotype 4 TIGR4 and their
isogenic mutants were grown on Columbia blood agar plates (Oxoid) containing
erythromycin (5 µg ml−1) and/or chloramphenicol (5 µg ml−1), or cultured in
Todd-Hewitt broth supplemented with 0.5% yeast extract (THY; Roth) or che-
mically defined medium (RPMImodi26; GE Healthcare, Bio-Sciences), respectively.
Cultivation of pneumococci on blood agar or in liquid cultures was performed at
37 °C and 5% CO2 without agitation.
Mutant construction. For the construction of the pneumococcal tacL mutants in
D39 and TIGR4, a DNA fragment consisting of the S. pneumoniae D39 spd_1672
gene and its up- and down-stream flanking regions were amplified by PCR from
genomic DNA using primer SPD1672_OLup_for and SPD1672_OLdwn_rev
(primers are listed in Supplementary Table 2). The purified PCR products were
cloned into pUC18 and E. coli DH5α chemically competent cells were transformed
with the resulting plasmid. The recombinant plasmid pNH1 harboring the desired
DNA insert was purified and used as template for an inverse PCR reaction with
primer InvrevKpnISPD1672 and InvforPstISPD1672. The deleted gene sequence
was replaced by an ermB gene, amplified by PCR from vector pTP1 using primer
InvrevKpnIErm and InforPstIErm. The final recombinant plasmid was used to
transform and mutagenize pneumococci. Transformation efficiency was evaluated
using the final recombinant plasmid vs. another gene deletion plasmid (for deletion
of the cbpL gene) in S. pneumoniae D39Δcps44. Remarkably, the transformation
efficiency was thereby significantly increased for the tacL deletion (2.8 colonies per
ng plasmid for cbpL vs. 29.8 colonies per ng plasmid for tacL).
Isogenic mutants were complemented by a pBAV1CpE-based in trans system;
pBAV1CpE was modified from pBAV1K-T5-gfp45, by exchanging the kanamycin-
resistance gene for a chloramphenicol-resistance gene and the T5 promotor for an
erythromycin promoter region (pE), which includes the ribosomal-binding site and
start codon. The complete spd_1672 gene was amplified by PCR using primer
1672_com_for and Spd1672_com_rev and the purified fragment was cloned into
pBAV1CpE. The resulting plasmid pBAV-tacL was used to transform isogenic tacL
mutants. The deletion of tacL as well as the in trans complementation were verified
using qRT-PCR (Supplementary Fig. 3).
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Real-time quantitative PCR (qRT-PCR). Encapsulated and nonencapsulated D39
wild-type strain, tacL-deficient mutant, and complemented mutant were cultivated
in THY until mid-log phase (A600= 0.35–0.45) and harvested for RNA isolation
using EURx GeneMatrix Universal RNA purification kit (roboklon). The quality of
RNA was checked by agarose gel electrophoresis and standard PCR using primer
EnoRT_F and EnoRT_R (see Supplementary Table 2). The synthesis of cDNA was
performed using the SuperScript III Reverse Transcriptase (ThermoFisher) and
hexameric_random primers (GE Healthcare) according to the manufacturer's
instructions. The quality of cDNA was controlled by PCR using primer EnoRT_F
and EnoRT_R and the concentration was measured by nanodrop. cDNA was
stored at −20 °C until further tests. For the qRT-PCR experiments, StepOnePlusTM
Real-Time PCR System (Applied Biosystems) and SYBR® Green Master Mix
(Biorad) were used in combination with tacL-specific primers as well as enolase-
primers as control (see Supplementary Table 2). The StepOne software (v. 2.3, Life
Technologies) was used for data analysis. The final results are presented as mag-
nitude of fluorescence (ΔRn) plotted against PCR cycle numbers.
Sequencing and bioinformatics analysis. Sequencing: 1 ng of purified chromo-
somal DNA from S. pneumoniae strains D39Δcps (PN111), D39ΔcpsΔtacL
(PN601), D39ΔcpsΔtacL pBAV-tacL (PN634), TIGR4Δcps (PN259), TIGR4Δcp-
sΔtacL (PN603), and TIGR4ΔcpsΔtacL pBAV-tacL (PN636) was used to prepare
individual libraries employing and following the Illumina Nextera© XT DNA
Library Prep Kit. An Agilent Technology 2100 Bioanalyzer served to verify tag-
mentation and the final library fragment size distribution on a high sensitivity
DNA chip. AMPure XP beads were used for DNA library purification. The final
pooled library was applied to a MiSeq Reagent v3 600cycle kit and sequenced on a
MiSeq system as 300 cycle paired-end run. The final library pool was spiked with
5% PhiX control library. A cluster density of 847± 25 (K mm−2) was achieved with
96.46± 1.48% of clusters passing filter specifications. 20.3 Mio reads (94.7%) of
21.1 Mio total reads passed filter specifications, leading to 12.52 Gbp of sequence
data. Index reads were evenly distributed across the six individual samples.
Generated FASTQ files were subjected to further bioinformatics analysis as
outlined below.
SNP detection and annotation: SNP detection was done for S. pneumoniae
D39Δcps, D39ΔcpsΔtacL, TIGR4Δcps, TIGR4ΔcpsΔtacL individually using
“snippy” (https://github.com/tseemann/snippy; parameter: minimum portion for
variant evidence: 60%; minimum coverage of variant site: ≥5 sequences reads). As
reference genome Streptococcus pneumoniae D39 (NC_008533.1) or Streptococcus
pneumoniae TIGR4 (NC_003028.3) was used.
The resulting SNPs for each group of mutants (D39Δcps vs. D39ΔcpsΔtacL)
and (TIGR4Δcps vs. TIGR4ΔcpsΔtacL) were merged and compared. Genome
coverage was estimated with qualimap46 using the same reference genomes as for
SNP detection.
Isolation of pneumococcal teichoic acids. Extraction and Isolation of LTA: LTA
purification was performed basically as described elsewhere7, but to optimize yield
of pnLTA, one specific detail has been modified. Pneumococcal cells were resus-
pended in citrate buffer (50 mM, pH 4.7) and disrupted three times by French press
(Constant Cell Disruption System, Serial No. 1020) at 10 °C at a pressure of 20
kPSI. SDS was added to a final concentration of 4% to the combined supernatants.
The solution was incubated for 30 min at 100 °C and was stirred afterwards
overnight at room temperature. The solution was centrifuged at 30,000×g for
15 min at 4 °C. The pellet was washed four times with citrate buffer using the
centrifugation conditions as above. The combined LTA-containing supernatants
and the resulting sediment, containing the crude PGN-WTA complex, were lyo-
philized separately. The resulting solids were both washed five times with ethanol
(centrifugation: 20 min, 20 °C, 10,650×g) to remove SDS and lyophilized (leading to
pellet A containing LTA and pellet B containing the PGN-WTA complex). For
LTA isolation, pellet A was resuspended in citrate buffer and extracted with an
equal volume of butan-1-ol (Merck) at room temperature under vigorous stirring.
The phases were separated by centrifugation at 2,100×g for 15 min at 4 °C. The
aqueous phase (containing LTA) was collected, and the extraction procedure was
repeated twice with the organic phase plus interphase. The combined aqueous
phases were lyophilized and subsequently dialyzed for 5 days at 4 °C against 50 mM
ammonium acetate buffer (pH 4.7; 3.5 kDa cutoff membrane); the buffer was
changed every 24 h. The resulting crude LTA was purified further by hydrophobic
interaction chromatography (HIC) performed on a HiPrep Octyl-Sepharose col-
umn (GE Healthcare; 16 × 100 mm, bed volume 20 ml). The crude LTA material
was dissolved in as little starting buffer (15% propan-1-ol (Roth) in 0.1 M
ammonium acetate (pH 4.7)) as possible and centrifuged at 13,000×g for 5 min at
room temperature and the resulting supernatant was lyophilized. The LTA-
containing pellet was dissolved in the HIC starting buffer at a concentration of
30 mgml−1 and purified by HIC using a linear gradient from 15 to 60% propan-1-
ol (Roth) in 0.1 M ammonium acetate (pH 4.7). LTA-containing fractions were
identified by a photometric phosphate test47. The phosphate-containing fractions
were combined, lyophilized, and washed with water upon freeze drying to remove
residual buffer.
Extraction and isolation of WTA: WTA isolation and extraction was carried out
as described elsewhere11, but with minor modifications. Pellet B (containing the
crude PGN-WTA complex), which arose during LTA isolation, was resuspended at
a concentration of 10 mgml−1 in 100 mM Tris-HCl (pH 7.5) containing 20 mM
MgSO4. DNase A and RNase I were added to final concentrations of 10 and 50 µg
ml−1, respectively. The suspension was stirred for 2 h at 37 °C. Subsequently,
10 mM CaCl2 and trypsin (100 µg ml−1) were added and the stirring was continued
overnight at 37 °C. SDS at a final concentration of 1% was added, and the mixture
was incubated for 15 min at 80 °C to inactivate the enzymes. The cell wall was
recovered by centrifugation for 45 min at 130,000×g at 25 °C. The resulting pellet
was resuspended in 0.8 ml 8M LiCl per 1 ml initially used Tris-HCl solution and
incubated for 15 min at 37 °C. After another centrifugation using the same
conditions as above, the pellet was resuspended in 1 ml 10 mM
ethylenediaminetetraacetic acid (EDTA, pH 7.0) per ml of the Tris-HCl solution
used initially and this sample was incubated at 37 °C for 15 min. The pellet was
washed twice with water. Finally, the pellet was resuspended in 2–4 ml of water and
lyophilized, yielding the purified PGN-WTA complex. Depending on the specific
research question, further chemical or enzymatic treatments were performed
subsequently.
Chemical and enzymatic treatments. Hydrazine treatment of LTA: Purified LTA
was dissolved at a concentration of 5 µg µl−1 in anhydrous hydrazine (N2H4; ICN
Biomedicals) before incubation for 1 h at 37 °C while being stirred. The reaction
was quenched by adding the same volume of acetone and dried under a stream of
nitrogen; the drying step was repeated twice. Subsequently, the crude de-O-acylated
LTA was purified by gel permeation chromatography (GPC) on a Bio-Gel P-10
(45–90 µm, BioRad; column size: 1.5 × 120 cm; buffer: 150 mM ammonium acetate
(pH 4.7)) column.
Enzymatic digestion of the PGN-WTA complex: To remove all amino acids from
the PGN, the PGN-WTA complex was dissolved in 50 mM Tris-HCl (pH 7.0;
10 mgml−1) and treated with the pneumococcal LytA amidase as described
elsewhere11. Recombinant His-tagged LytA amidase (10 µg LytA per mg) was
added in three aliquots after 0, 24, and 48 h for a total period of incubation of 72 h
at 37 °C. Subsequently, the enzyme was inactivated by boiling for 5 min at 100 °C.
After centrifugation (25,000×g, 15 min, 20 °C), the supernatant was collected and
lyophilized. The crude LytA-treated PGN-WTA complex was further purified by
GPC on a Bio-Gel P-30 (45–90 µm, BioRad; column size: 1.5 × 120 cm; buffer:
150 mM ammonium acetate (pH 4.7)) column. The high molecular weight material
obtained (~12 mg) was further digested with lysozyme (200 µg; Sigma) and
mutanolysin (200 µg; Sigma) in an 800 µl reaction mixture containing sodium
phosphate (20 mM; pH 4.8) and sodium azide (0.02%) at 37 °C overnight. The
enzymes were inactivated by heating at 100 °C for 5 min. The soluble material was
recovered by centrifugation (18,000×g, 10 min, 20 °C) and lyophilized. Isolation of
the pnWTA bound to small PGN fragments was achieved by a final GPC using the
conditions mentioned above.
NMR spectroscopy. NMR spectroscopic measurements were performed in D2O at
300 K on a Bruker AvanceIII 700 MHz (equipped with an inverse 5 mm quadruple-
resonance Z-grad cryoprobe). Deuterated solvents were purchased from Deutero
GmbH (Kastellaun, Germany). Acetone was used as an external standard to cali-
brate 1H (δH 2.225) and 13C (δC 30.89) NMR spectra. 31P NMR spectra (δP 0.0)
were calibrated with 85% phosphoric acid in D2O as an external standard. 1H NMR
assignments were confirmed by two-dimensional 1H, 1H COSY and TOCSY
experiments, and 13C NMR assignments were indicated by two-dimensional 1H,
13C HSQC, based on the 1H NMR assignments. Interresidual connectivity and
further evidence for 13C assignment were obtained from two-dimensional 1H, 13C
HMBC and 1H, 13C HSQC-TOCSY experiments. Phosphate group connectivity
was assigned by two-dimensional 1H, 31P HMQC and 1H, 31P HMQC-TOCSY. All
data were acquired and processed using Bruker TOPSIN V 3.0 or higher.
Mass spectrometry. To analyze the pnWTA bound to small PGN fragments,
electrospray ionization fourier-transform ion cyclotron resonance mass spectro-
metry (ESI-FT-ICR-MS) was performed on a 7 Tesla APEX Qe instrument (Bruker
Daltonics, Bremen, Germany) using negative-ion mode and a water/propan-2-ol/
7 M triethylamine/acetic acid mixture (50:50:0.06:0.02 v/v/v/v) as solvent, as
described previously6. MS analysis of hydrazine-treated LTA was done on a Q
Exactive Plus (Thermo Scientific, Bremen, Germany) in negative-ion mode using
the same solvent. A Triversa Nanomate (Advion, Ithaca, USA) ion source was used
with a spray voltage set to −1.1 kV. The mass scale was calibrated externally with
glycolipids of known structure, and all spectra were charge deconvoluted. The
given mass numbers refer to the monoisotopic mass of the neutral molecules.
Electron microscopy. Field emission scanning electron microscopy: bacteria were
fixed in the growth medium with 5% formaldehyde and 2.5% glutaraldehyde for 1 h
on ice and washed with HEPES buffer (HEPES 0.1 M, 0.09M sucrose, 10 mM
CaCl2, 10 mM MgCl2, pH 6.9). An aliquot of 50 µl of the fixed bacterial solution
was placed on poly-L-lysine coated coverslips and allowed to settle for 10 min. After
fixation with 2% glutaraldehyde in PBS for 5 min at room temperature, the cov-
erslips were washed with TE buffer (20 mM Tris-HCl, 1 mM EDTA, pH 6.9) before
dehydrating in a graded series of acetone (10, 30, 50, 70, 90, and 100%) on ice for
10 min for each step. Samples in the 100% acetone step were allowed to reach room
temperature before another change in 100% acetone before critical-point drying
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with liquid CO2 (CPD 30, Balzers, Liechtenstein). Dried samples were covered with
a palladium–gold film by sputter coating (SCD 500, Bal-Tec, Liechtenstein) before
examination in a field emission scanning electron microscope Zeiss Merlin
(Oberkochen, Germany) using the HESE2 Everhart Thornley SE detector and the
in-lens SE detector in a 25:75 ratio at an acceleration voltage of 5 kV.
Transmission electron microscopy: bacteria were fixed as above and further fixed
with osmium tetroxide (1% in HEPES buffer) for 1 h at room temperature. After
washing with HEPES buffer, samples were dehydrated with 10, 30, and 50%
acetone on ice before incubation in 70% acetone with 2% uranyl acetate overnight
at 7 °C. Samples were further dehydrated with 90 and 100% acetone on ice, allowed
to reach room temperature and further dehydrated with 100% acetone, then
changed into 100% ethanol. Subsequently, samples were infiltrated with the
aromatic acrylic resin LRWhite. After polymerization for 2 days at 50 °C, ultrathin
sections were cut with a diamond knife, collected onto butvar-coated 3000 mesh
grids, and counterstained with 4% aqueous uranyl acetate for 3 min. Samples were
imaged in a Zeiss TEM 910 at an acceleration voltage of 80 kV and at calibrated
magnifications.
Contrast and brightness were adjusted with Adobe Photoshop CS3.
Generation of antibodies. Polyclonal antibodies against analyzed CBPs were
raised in mice using routine immunization protocols. Briefly, CD-1 mice were
immunized intraperitoneally with 20 µg recombinant protein and Freund's
incomplete adjuvant (Sigma-Aldrich, Darmstadt, Germany) (50:50 v/v). At day 14
and 28, mice were boosted with 20 µg protein and Freund's incomplete adjuvant
(50:50 v/v). Mice were bled at day 42 and polyclonal IgG were purified from serum
using protein A-Sepharose (Sigma-Aldrich, Darmstadt, Germany). Antibodies are
listed in Supplementary Table 2.
Flow cytometry. S. pneumoniae D39 wild type, its isogenic tacL mutant, and the
complemented mutant were cultivated in THY medium to mid-log phase, har-
vested at 3,275×g for 6 min, and washed with PBS (pH 7.4). For quantification of
the capsule content, a 100 µl suspension containing 4 × 108 bacteria was incubated
with anti-capsular polysaccharide antisera (SSI Type serum 2, Statens Serum
Institute) (1:500 in PBS) for 30–45 min at 37 °C and 5% CO2 in 96-well plates (U-
bottom, Greiner Bio-One). After washing, samples were incubated with a sec-
ondary goat anti-rabbit IgG-coupled Alexa488-labeled antibody (Invitrogen) (1:500
in PBS, 30–45 min, 37 °C). After washing with PBS, bacteria were fixed with 1%
formaldehyde overnight at 4 °C.
The abundance of CBPs as well as the quantity of teichoic acids in
nonencapsulated D39 wild-type, mutant and complemented strains were measured
by flow cytometry after fixation with 1% formaldehyde for 1 h at 4 °C. Two
hundred µl suspensions containing 8 × 108 bacteria were incubated with specific
polyclonal antibodies against different CBPs (1:500 in PBS), or for the
quantification of TAs with antibodies against P-Cho (TEPC-15) or Forssman
antigen (15 min at 37 °C and 5% CO2) in 96-well plates (U-bottom, Greiner Bio-
One). After washing, samples were incubated with a secondary goat anti-IgG-
coupled Alexa488-labeled antibody (Invitrogen) (15 min, 37 °C). Fluorescence was
determined using a FACS Calibur™ (BD Biosciences).
Immunoblot analysis. S. pneumoniae D39, its isogenic tacL mutant, and the
complemented mutant were grown in THY medium until an A600 of 0.35–0.45 was
reached, harvested by centrifugation at 3270×g at 4 °C for 6 min, and resuspended
in 1 ml PBS buffer at pH 7.4. A total of 2 × 108 cells per well were loaded and run
on a 12% SDS-PAGE before transferring to a nitrocellulose membrane by semidry
blotting. The membranes were blocked for 2 h at room temperature using 5%
skimmed milk (Roth) and Tris-buffered saline (TBS; pH 7.4) and incubated
overnight at 4 °C with mouse polyclonal antibodies against different CBPs (1:500 in
5% skimmed milk + TBS 0.01% Tween (T-TBS)). A rabbit polyclonal antibody
against enolase (1:25,000 in 5% skimmed milk + T-TBS) was used as a loading
control. The membranes were washed with T-TBS, CBPs were detected with the
secondary fluorescence-labeled IRDye® 800CW. Goat α-mouse IgG and enolase
were detected with the fluorescence-labeled IRDye® 680RD. Goat α-rabbit IgG
antibody was detected by incubation with the appropriate antibody (1:15,000 in 5%
skimmed milk in T-TBS) for 45 min in the dark at room temperature; the mem-
branes were washed with T-TBS and finally once with TBS. The scanning of the
membranes was performed using an Odyssey® CLx (LI-COR) scanner.
Triton X-100-induced autolysis assay. S. pneumoniae D39 wild-type, mutant,
and complemented strain were cultivated in THY medium to mid-log phase,
harvested at 3275×g for 6 min, and washed with PBS (pH 7.4). A 1 ml suspension
containing 1 × 109 bacteria was incubated with a final concentration of 0.01%
Triton X-100 (Sigma-Aldrich, Darmstadt, Germany) and incubated at 37 °C.
Bacterial cell lysis was monitored by measuring absorbance at 600 nm at predefined
time points.
Epithelial adherence assay. Pneumococcal adherence to epithelial cells was
analyzed with human A549 cells (ATCC® CCl-185TM) as described48. Briefly,
confluent epithelial cells, grown on glass coverslips (Hartenstein; in 24-well plates,
~1 × 105 cells per well) were inoculated with 5 × 106 mid-exponentially grown
pneumococci and incubated in infection medium (DMEM (HyClone™) + 1% heat-
inactivated fetal bovine serum (FBS)) at 37 °C and 5% CO2. Subsequently, cells
were washed three times with phosphate-buffered saline containing 1% FBS
(Gibco) to remove unbound bacteria. Afterwards, bacteria were fixed with PBS
containing 1% para-formaldehyde (PFA, Roth).
Immunofluorescence microscopy. Fixed pneumococci, bound to A549 cells were
washed three times with PBS and blocked for 1 h at room temperature using PBS +
10% FBS. After washing, samples were incubated for 1 h at room temperature with
a polyclonal antibody (1:500, Davids Biotechnologie GmbH) against pneumococci
(generated in rabbit against heat-inactivated S. pneumoniae TIGR4 and D39). As a
secondary antibody, fluorescence-labeled Alexa-Fluor488 goat anti-rabbit antibody
(Abcam) was used (1:500, 1 h, room temperature). Bacterial adherence was mon-
itored for at least 20 cells per class coverslip using fluorescence microscopy. Each
experiment was repeated three times in duplicate. All data are reported as means ±
s.d. Statistical analysis was performed using the unpaired two-tailed Student’s t test.
In all analysis, a p value of <0.05 was considered statistically significant.
Phagocytosis experiments. Antibiotic protection assay: A confluent layer of
monocytic THP-1 cells (ATCC® TIB-202TM) grown in 24-well plates (3 × 105 cells
per well in RPMI-1640 (HyClone™) supplemented with 10% heat-inactivated fetal
bovine serum (FBS, Gibco)) was differentiated to phagocytes by the addition of 200
nmol ml−1 phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich) and incubated
for 48 h at 37 °C and 5% CO2. Afterwards, THP-1 cells were washed with RPMI-
1640 supplemented with 10% heat-inactivated FBS and incubated for another 24 h
at 37 °C and 5% CO2. Prior infection pneumococci were cultured in THY to mid-
log phase (A600= 0.35–0.45), centrifuged, and washed with infection medium
(RPMI-1640 supplemented with 1% heat-inactivated FBS). THP-1 cells were
washed and infected with pneumococci in 500 µl infection medium. Infection was
synchronized by centrifugation (2 min, 300×g) to initiate a simultaneous contact
between bacteria and phagocytes. Afterwards cells were incubated at 37 °C and 5%
CO2 for different time periods. After infection, cells were washed with infection
medium and incubated with Penicillin G (100 unit ml−1, Sigma-Aldrich) and
Gentamicin (0.1 mg ml−1, Sigma-Aldrich) for 1 h at 37 °C and 5% CO2 to kill
extracellular bacteria. Then, phagocytes were washed and lysed with 1% saponin
(Sigma-Aldrich) to release intracellular pneumococci. Colony-forming units (cfu)
of intracellular bacteria were determined by plating bacteria in appropriate dilu-
tions on blood agar plates (Oxoid)49. Time-dependent killing of intracellular
pneumococci was evaluated by killing extracellular pneumococci using antibiotics
as described above. Afterwards, phagocytes were further incubated in infection
medium for different time periods (0–3 h). Intracellular bacterial cfu were mon-
itored as described above. All experiments were repeated four times as duplicates.
Data were normalized in the antibiotic protection assays to the multiplicity of
infection (MOI) or in the time-dependent killing to recovered bacteria at time
point 0 h. All assays were analyzed using one-way ANOVA with Bonferroni
correction.
Double immunofluorescence staining and microscopy. PMA-differentiated
THP-1 cells (3 × 105 cells per well) were grown on sterile glass coverslips (12 mm,
Hartenstein) and infected with pneumococci as described above. After infection,
THP-1 cells were washed with infection medium and fixed with 4% para-
formaldehyde (Roth) over night at 4 °C. Glass coverslips were washed with PBS and
blocked with PBS + 10% heat-inactivated FBS for 1 h. After washing, extracellular
bacteria were stained using a polyclonal α-pneumococci IgG (1:500) and an Alexa-
Fluor488-labeled secondary goat α-rabbit IgG (1:500, Abcam) for 30 min at room
temperature. Glass coverslips were washed thrice with PBS following permeabili-
zation of THP-1 cells with 0.1% Triton X-100 in PBS (10 min, room temperature).
After washing, intracellular pneumococci were stained using a polyclonal α-
pneumococci IgG (1:500) and a secondary Alexa-Fluor568-labeled goat α-rabbit IgG
(1:500, Abcam) for 30 min at room temperature. Experiments were repeated three
times as duplicates. For statistical analysis, 50 cells per glass coverslip were analyzed
for the number of intracellular bacteria. Data were normalized to the MOI. All
assays were analyzed using one-way ANOVA with Bonferroni correction. In all
analysis, a p value of <0.05 was considered statistically significant.
Cell lines. All cell lines used in this study were purchased from ATCC (A549:
ATCC CCL-185; THP-1: ATCC TIB-202) and have been tested to be mycoplasma-
negative by PCR and scanning electron microscopy.
Acute mouse pneumonia and systemic infection model. Eight- to 10-week-old
female CD-1 mice (outbred, Charles River, Sulzfeld, Germany) were intranasally
infected with bioluminescent pneumococci as described recently50. Briefly, pneu-
mococci were cultured to mid-exponential phase (A600= 0.35) in THY medium
containing 10% heat-inactivated fetal bovine serum. After centrifugation, the
infection dose (20 µl) was adjusted to ~2.5 × 107 cfu in PBS (pH 7.4). For nasal
infection, mice were anesthetized by intraperitoneal injection of ketamine/xylazine
(Ketanest S, Pfizer Pharma, Karlsruhe, Germany; Rompun, Provet AG, Lyssach,
Germany), and bacteria were administered dropwise into the nostrils. The cfu of
the infection dose was confirmed by plating of serial dilutions of the inoculum on
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blood agar plates. Mice were monitored for survival and imaged for biolumines-
cence at pre-chosen intervals using the IVIS® Spectrum Imaging System (Caliper
Life Sciences, Hopkinton, USA). For the systemic infection model, an infection
dose of 3 × 103 cfu was administered intraperitoneally in a volume of 200 µl PBS
(pH 7.4). All animal experiments were conducted according to the German reg-
ulations of the Society for Laboratory Animal Science (GV-SOLAS) and the Eur-
opean Health Law of the Federation of Laboratory Animal Science Associations
(FELASA). All experiments were approved by the Landesamt für Landwirtschaft,
Lebensmittelsicherheit und Fischerei Mecklenburg – Vorpommern (LALLFV M-V,
Rostock, Germany, permit no. 7221.3-1-056/16-1).
Data availability. Raw FASTQ files containing S. pneumoniae genomic sequence
data were submitted to the EMBL-EBI European Nucleotide Archive (ENA) and
stored in the Short Read Archive (SRA) under the study accession number
RJEB18558. All other relevant data supporting the findings of the study are
available in this article and its Supplementary Information files, or from the cor-
responding authors on request.
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